Dr. Julie A. Margenthaler MD
Oncologist | Medical Oncology
660 South Euclid Avenue Campus Box 8109 St. Louis Missouri, 63110Rating
5/5
About
Julie A. Margenthaler, MD, FACS, works at Washington University St. Louis in St. Louis, Missouri. An Associate Professor at the University, Dr. Margenthaler specializes in breast oncology, particularly breast cancer in those younger than 40. Author of over 20 journal articles on this topic and more, Dr. Margenthaler also serves Barnes Jewish Hospital and their affiliates.
Education and Training
Southern Illinois University School of Medicine
Southern Il Univ Sch Of Med- Springfield Il 1997
Board Certification
General Surgery
SurgeryAmerican Board of SurgeryABS
Provider Details
Expert Publications
Data provided by the National Library of Medicine- The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
- CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
- Transfer of "infectious" cardiac allograft tolerance induced by donor-specific transfusion.
- Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
- Development of infectious tolerance after donor-specific transfusion and rat
- Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
- Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
- Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury.
- "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
- Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
- Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
- The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C
- Regional oral tolerance in transgenic 2C mice.
- Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
- Metastatic disease to the breast: the Washington University experience.
Clinical Trials
- Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
- Compare Outcomes Between Two Acellular Dermal Matrices
- LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
- Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
- Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Areas of expertise and specialization
Awards
- James Ewing Foundation grant, Society of Surgical Oncology (2006-2007)
- 2006-2007 James Ewing Foundation grant, Society of Surgical Oncology
- 2000-2002 SUS/Ethicon Research Award
- 2000-2001 ALF Postdoctoral Fellowship Award
- 2004 Resident Teaching Award
Treatments
- Breast Cancer, Breast Surgery, Breast Issues
Fellowships
- Research, Washington University School of Medicine, St. Louis MO 2002
- Breast Disease, Washington University School of Medicine, St. Louis MO 2006
Fellowships
- Washington University School of Medicine (Breast disease)
Professional Society Memberships
- American Medical Association, Association of Woman Surgeons, American Society of Clinical Oncology, American Society of Breast Surgeons, St. Louis Surgical Society
What do you attribute your success to?
- Having the Best Training and Working at a Facility with Terrific Treatment Centers and Resources
Hobbies / Sports
- Boating, Baseball, Live Music, Travel
Favorite professional publications
- Journal of Clinical Oncology, Annals of Surgical Oncology
Dr. Julie A. Margenthaler MD's Practice location
St. Louis, Missouri 63110Get Direction
Practice At 216 S Kingshighway Blvd
216 S Kingshighway Blvd -Saint Louis, MO 63110Get Direction
Dr. Julie A. Margenthaler MD's reviews
Write ReviewPatient Experience with Dr. Margenthaler
Recommended Articles
![]()
Hope for Recurring Ovarian Cancer PatientsOvarian cancer, known as the ‘silent killer’, is the 5th leading cause of cancer-related deaths among women ages 35 to 74. As of this year, it is estimated that more than 22,000 new cases of ovarian cancer will be diagnosed. ...
![]()
Colon CancerWhat is colon cancer?Colon cancer is cancer of the large intestine, also known as the colon. If the last segment of the colon, the rectum, has a cancerous growth, it is known as rectal carcinoma. These two conditions are collectively referred to as colorectal cancer.Carcinoma of the colon is the...
![]()
She Survived Breast Cancer, But Says a Treatment Side Effect Almost Killed HerIn 2014, 47-year-old Virginia Harrod found a lump in her breast, which was actually stage III breast cancer. She was immediately started on shock-and-awe chemotherapy, but as it turned out, the cancer was chemo-resistant and the tumor only grew with each treatment. Harrod then underwent a double...
![]()
Breast Cancer: Why it's Absolutely Essential for Men to get Checked, tooBreast cancer draws a lot of publicity and attention, and when many think of breast cancer, they are likely thinking of women. This makes sense because “breast” is typically a female word, and every year there are tons of breast cancer awareness campaigns that revolve around women and are...
![]()
What Is Liver Cancer Carcinoma?What Is Carcinoma?When you talk to an Oncologist to inform you on the types of cancer existent at the moment or visit the internet and search for the same, you will be surprised just how many are there. Thank God that the advancement seen in the field of technology has brought tremendous benefits to...
![]()
Alternative Treatments for Bladder CancerAlternative Treatments for Bladder CancerCancer occurs in various stages, and as it moves from one stage to another, it gets worse. Therefore, as the condition progresses, more effective methods of treatment have to be applied. At times, even two treatment methods can be applied together.In...
Nearby Providers
![]()
Dr. Carl Freter MD3655 Vista Ave St Louis MO 63110![]()
Dr. Elaine Majerus MD1 Barnes Jewish Hospital Plz Saint Louis MO 63110![]()
Dr. Alaa A. Elbendary M.D.11652 Studt Ave Saint Louis MO 63141![]()
Mateusz Opyrchal MD PHD4921 PARKVIEW PL SAINT LOUIS MO 63110![]()
Dr. Steven Mark Sorscher MD4921 Parkview Pl Saint Louis MO 63110![]()
Dr. Susan L Luedke M.D.6435 Chippewa St Saint Louis MO 63109
Nearest Hospitals
ST LOUIS CHILDRENS HOSPITALl
ONE CHILDRENS PLACE SAINT LOUIS MO 63110SHRINERS HOSPITALS FOR CHILDRENl
4400 CLAYTON AVE SAINT LOUIS MO 63110ST LOUIS CHILDRENS HOSPITALl
ONE CHILDRENS PLACE SAINT LOUIS MO 63110SHRINERS HOSPITALS FOR CHILDRENl
4400 CLAYTON AVE SAINT LOUIS MO 63110